Genetic variation of the dihydrofolate reductase gene in Plasmodium vivax in Snoul, northeastern Cambodia

This publication has 18 references indexed in Scilit:

• Novel Point Mutations in the Dihydrofolate Reductase Gene of Plasmodium vivax : Evidence for Sequential Selection by Drug Pressure
  Antimicrobial Agents and Chemotherapy, 2003
• Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment ofPlasmodium falciparumMalaria
  The Journal of Infectious Diseases, 2002
• Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance
  Molecular and Biochemical Parasitology, 1998
• Analysis of the Plasmodium vivax dihydrofolate reductase–thymidylate synthase gene sequence
  Gene, 1998
• Plasmodium falciparum:Molecular Characterization of Multidrug-Resistant Cambodian Isolates
  Experimental Parasitology, 1996
• Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum
  Molecular and Biochemical Parasitology, 1995
• In vitrosusceptibility of Cambodian isolates ofPlasmodium falciparumto halofantrine, pyronaridine and artemisinin derivatives
  Pathogens and Global Health, 1994
• Sulfadoxine-Pyrimethamine for the Treatment of Acute Malaria in Children in Papua New Guinea
  The American Journal of Tropical Medicine and Hygiene, 1982
• Treatment of vivax malaria with sulfadoxine-pyrimethamine and with pyrimethamine alone
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1979
• CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN THAILAND
  The Lancet, 1965